Share Email Print

Proceedings Paper • new

Single particle automated Raman trapping analysis (Conference Presentation)
Author(s): Jelle Penders; Isaac Pence; Conor Horgan; Mads Bergholt; Chris Wood; Adrian Najer; Ulrike Kauscher; Anika Nagelkerke; Molly M. Stevens
cover GOOD NEWS! Your organization subscribes to the SPIE Digital Library. You may be able to download this paper for free. Check Access

Paper Abstract

Comprehensive single nanoparticle analysis of synthetic drug delivery systems, as well as natural occurring particles such as Extracellular Vesicles (EVs), is still a major challenge in the field, and is necessary to enhance their successful design, screening and study towards translational application. Investigating population heterogeneity is essential for nanoparticles, as their behaviour, characteristics and thus applicability are strongly affected by this, and cannot be resolved with conventional bulk analysis techniques. Here, we present a dedicated platform for comprehensive Single Particle Automated Raman Trapping Analysis (SPARTA). Nanoparticles ranging from synthetic polymer particles to liposomes or EVs can be integrally analysed by SPARTA without any modification, to obtain their size, determine functionalisation and composition, and monitor dynamic reactions occurring on their surface. The single nanoparticle nature of this approach allows highly detailed investigation in particle heterogeneity, resolving particle mixtures and tracking sequential functionalisations and dynamics on the particle surface. By using a Raman solution marker we demonstrated for the first time the capability to size single nanoparticles in a trap solely by Raman scattering, while simultaneously obtaining their compositional information, allowing novel insights in size-composition relationships. In addition, SPARTA can be applied to study in great detail the biochemical profiles of single EVs from cancerous and non-cancerous origin, towards the use of EVs as cancerous biomarkers for diagnosis, disease progression and evaluating therapeutic efficacy. SPARTA has great potential to critically impact fields from nano drug delivery system design to cancer biomarker identification and profiling.

Paper Details

Date Published: 13 March 2019
Proc. SPIE 10892, Colloidal Nanoparticles for Biomedical Applications XIV, 108920K (13 March 2019); doi: 10.1117/12.2508224
Show Author Affiliations
Jelle Penders, Imperial College London (United Kingdom)
Isaac Pence, Imperial College London (United Kingdom)
Conor Horgan, Imperial College London (United Kingdom)
Mads Bergholt, Imperial College London (United Kingdom)
Chris Wood, Imperial College London (United Kingdom)
Adrian Najer, Imperial College London (United Kingdom)
Ulrike Kauscher, Imperial College London (United Kingdom)
Anika Nagelkerke, Imperial College London (United Kingdom)
Molly M. Stevens, Imperial College London (United Kingdom)

Published in SPIE Proceedings Vol. 10892:
Colloidal Nanoparticles for Biomedical Applications XIV
Marek Osiński; Wolfgang J. Parak, Editor(s)

© SPIE. Terms of Use
Back to Top